Simon Hoffenberg
7Patents
4h-index
28Co-inventors
53Inventor score
Filing activity: Mar 2, 2011 → Jul 9, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8586056B2 | HIV-1 envelope glycoprotein | Chemistry; Metallurgy | 11 | Active |
| US9347065B2 | Methods to improve vector expression and genetic stability | Chemistry; Metallurgy | 5 | Active |
| US10744189B2 | Lysin polypeptides active against Gram-negative bacteria | Emerging Cross-Sectional Technologies | 5 | Active |
| US9738688B2 | HIV-1 envelope glycoprotein | Chemistry; Metallurgy | 4 | Active |
| US11413334B2 | Lysin polypeptides active against Gram-negative bacteria | Emerging Cross-Sectional Technologies | 1 | Active |
| US9944935B2 | Methods to improve vector expression and genetic stability | Chemistry; Metallurgy | 0 | Active |
| US9562078B2 | Methods for identifying broadly neutralizing antibodies utilizing recombinant HIV-1 envelope glycoproteins comprising stabilizing mutations | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.